Cocrystal Pharma, Inc.COCPNASDAQ
Loading
Cash Generation ExpandingExpanding
Percentile Rank47
Studio
Year-over-Year Change

Cash generated from core business operations

Latest
$-9.80M
↑ 16% vs avg
Percentile
P47
Within normal range
Streak
1 yr
Consecutive growthExpanding
Average
$-11.63M
Historical baseline
PeriodValueYoY Change
TTM$-9.80M+40.5%
2024$-16.48M-12.4%
2023$-14.67M+31.6%
2022$-21.43M-68.5%
2021$-12.72M-29.4%
2020$-9.83M-528.9%
2019$-1.56M+81.1%
2018$-8.29M-20.1%
2017$-6.90M+52.9%
2016$-14.65M-